1.
Yu H, Mei X, Zhang X, Qian N, Yu Q, Zhou H. SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling. Bangladesh J Pharmacol [Internet]. 2024 Jun. 15 [cited 2024 Nov. 21];19(2):52-8. Available from: https://banglajol.info/index.php/BJP/article/view/72787